Belite Bio Inc ADR

Market Cap

$6B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$139.63-$19.64 (-12.33%)

Jun 8, 2026

52W High $190.3052W Low $56.81

Company Details

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), ...

CEO

—

IPO Date

Apr 29, 2022

Website

www.belitebio.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$90M

EPS (Diluted)

Free Cash Flow

-$11M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

Mar 31, 2026

FY 2025

Mar 31, 2026

Q4 2025

Mar 31, 2026

Q3 2025

Dec 1, 2025

Q2 2025

Aug 11, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee